Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide7 min read

Best Sprout Alternatives 2026 (From $49/mo)

Six real alternatives to Sprout's GLP-1 program ($99/month on a 12-month plan), from welludr at $41 to altRx's three-brand shelf, by reason to switch.

Updated September 24, 2026

Medically reviewed on

How we review

Key takeaways

  • People leave Sprout for price (its $149 month-to-month semaglutide sits $50-90/month above the value tier), track record (it is a newer brand), or a bigger brand-name selection.
  • welludr sells the same compounded semaglutide for $41/month on a 12-month plan with a warranty - $696/year less than Sprout's 12-month plan; Sprout's counter is 2-day fulfillment vs 3-5 days.
  • altRx is the only other ranked provider with brand-name medication, and does it bigger and cheaper - Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 - plus $89 compounded semaglutide with BNPL.
  • Other exits: embody $49 flat with free expedited cold-chain delivery, Medvi $99 promo with coaching and video visits, HealthRx $125 after a $39 first month, DirectMeds $249 with needle-free drops.

Name the reason before you name the alternative

The short answerPeople leave Sprout for price, since its $149 month-to-month semaglutide sits $50 to $90 a month above the value tier, for track record, since it is a newer brand, or for a bigger brand-name selection. welludr sells the same compounded semaglutide for $41 a month on a 12-month plan with a weight-loss warranty; altRx is the only other ranked provider with brand-name medication, at Ozempic $1,149, Zepbound $1,249 and Wegovy $1,579 plus $89 compounded semaglutide; embody, Medvi, HealthRx and DirectMeds are the other exits.

People shop for Sprout alternatives for three distinct reasons, and each points somewhere different. If it's price - Sprout's $149 month-to-month semaglutide sits $50-90/month above the value tier - the answer is the budget lane. If it's track record - Sprout is a newer brand - the answer is a longer-established provider. And if it's brand-name selection - Sprout stocks Wegovy only, at $1,799 - the answer is the one provider with a bigger, cheaper shelf.

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review
3
TrimRx logo

Very Good

8.9out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA
  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Telehealth GLP-1 program built around custom dosing and unlimited provider check-ins - compounded semaglutide $149/month, the same at every dose, and tirzepatide $259/month.

Read full TrimRx review

The map, by what you'd actually gain

AlternativeSemaglutideWhat it beats Sprout onWhat you give up
welludr$41/moPrice + warranty2-day speed; Wegovy option
embody$49/moPrice, free expedited cold-chain delivery, LegitScriptBrand-name option
altRx$89/moPrice + 3-brand shelf incl. cheaper WegovySpeed (5-7 day shipping)
Medvi$99/mo promoPrice + coaching + video visitsBrand-name option
HealthRx$125/mo*Overnight delivery, LegitScriptHigher monthly price
DirectMeds$249/moNeedle-free sublingual dropsBrand-name option

*After a $39 first month. Every provider here gates treatment behind a licensed-provider review - that never varies, and shouldn't.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

The two matchups that decide it for most people

Sprout vs the price floor: welludr sells the same compounded semaglutide for $41/month on a 12-month plan with a warranty and a 4.7 published record - $696/year less than Sprout's 12-month plan. Sprout's counters are real but narrow: 2-day fulfillment vs 3-5 business days, Wegovy on the shelf, and a month-to-month option at $149. The full head-to-head is in Sprout vs welludr.

Sprout vs the other brand shelf: altRx is the only other provider we rank with brand-name medication, and it does it bigger and cheaper - Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 - on top of $89 compounded semaglutide with BNPL. Sprout's remaining edge there is pure speed: 2 days vs 5-7. That comparison is in altRx vs Sprout.

→ Six questions, one personalized answer: take the matching quiz

This article is general information, not medical advice. Prices as listed at the time of writing.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)